TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Inoviq Ltd ( (AU:IIQ) ) is now available.
INOVIQ Ltd has issued 27,142,856 fully paid ordinary shares at an issue price of A$0.35 per share, utilizing its existing placement capacity. This strategic move is part of the company’s efforts to enhance its financial resources, potentially impacting its operations and industry positioning by supporting its ongoing and future projects in cancer diagnostics and therapeutics.
The most recent analyst rating on (AU:IIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Inoviq Ltd stock, see the AU:IIQ Stock Forecast page.
More about Inoviq Ltd
INOVIQ Ltd is a leader in exosome technology, focusing on next-generation diagnostics and therapeutics to transform cancer care. Their product portfolio includes commercial-stage exosome isolation products, clinical-stage diagnostics for ovarian and breast cancers, and a preclinical CAR-exosome therapeutic program for solid tumors.
Average Trading Volume: 109,638
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$41.3M
See more insights into IIQ stock on TipRanks’ Stock Analysis page.